The Impact of Long-term Pessary Use on Pelvic Organ Prolapse oìduring Covid-19 Pandemic in Patients Attending Surgery

Launched by IRCCS SAN RAFFAELE · Jan 29, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of using a vaginal pessary on women with pelvic organ prolapse, particularly during the waiting period for surgery. A pessary is a device that is placed in the vagina to help support pelvic organs that may be sagging or prolapsing. The trial focuses on women aged 45 to 80 who have been diagnosed with more advanced stages of pelvic organ prolapse. Researchers want to see if using a pessary can improve their condition while they wait for surgery.

To be eligible for the trial, participants must be women between 45 and 80 years old who have a specific type of pelvic organ prolapse that requires surgery. However, women with certain health issues or those who have had previous pelvic surgeries will not be able to participate. Those who join the study can expect to be fitted with a pessary and monitored to see how it affects their symptoms. This trial is important because it may provide insights into managing pelvic organ prolapse while patients wait for surgical treatment, especially during challenging times like the COVID-19 pandemic.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Pelvic organ prolapse with POP-Q stage \>/= 3 in anterior and/or central compartments
• • Women between 45 and 80 years old
• Exclusion Criteria:
• • Women who refuse to participate in the study
• • Patients without baseline POPQ examination documented or with a pessary previously positioned
• • Previous pelvic surgeries
• • Women with any contraindication for surgery or preference for conservative treatment only (pelvic muscle exercise, vaginal pessary)
• • Women who are not successfully fitted with pessaries
• • Current genital ulcers/infections
• • Active or chronic pelvic infection
• • Women who are mentally incapable of completing the questionnaires.